Aspirin eugenol ester regulates cecal contents metabolomic profile and microbiota in an animal model of hyperlipidemia
Abstract Background Hyperlipidemia, with an increasing of prevalence, has become one of the common metabolic diseases in companion animal clinic. Aspirin eugenol ester (AEE) is a novel compound that exhibits efficacious anti-hyperlipidemia activities. However, its mechanisms are still not completely...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-12-01
|
Series: | BMC Veterinary Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12917-018-1711-x |
_version_ | 1818292422503825408 |
---|---|
author | Ning Ma Xi-Wang Liu Xiao-Jun Kong Shi-Hong Li Zeng-Hua Jiao Zhe Qin Ya-Jun Yang Jian-Yong Li |
author_facet | Ning Ma Xi-Wang Liu Xiao-Jun Kong Shi-Hong Li Zeng-Hua Jiao Zhe Qin Ya-Jun Yang Jian-Yong Li |
author_sort | Ning Ma |
collection | DOAJ |
description | Abstract Background Hyperlipidemia, with an increasing of prevalence, has become one of the common metabolic diseases in companion animal clinic. Aspirin eugenol ester (AEE) is a novel compound that exhibits efficacious anti-hyperlipidemia activities. However, its mechanisms are still not completely known. The objective of present study was to investigate the intervention effects of AEE on cecal contents metabonomics profile and microbiota in hyperlipidemia rats. Results Three groups of rats were fed with a control diet, or high fat diet (HFD) containing or not AEE. The results showed the beneficial effects of AEE in HFD-fed rats such as the reducing of aspartate aminotransferase (AST) and total cholesterol (TCH). Distinct changes in metabonomics profile of cecal contents were observed among control, model and AEE groups. HFD-induced alterations of eight metabolites in cecal contents mainly related with purine metabolism, linoleic acid metabolism, glycerophospholipid metabolism, sphingolipid metabolism and pyrimidine metabolism were reversed by AEE treatment. Principal coordinate analysis (PCoA) and cluster analysis of microbiota showed altered patterns with distinct differences in AEE group versus model group, indicating that AEE treatment improved the negative effects caused by HFD on cecal microbiota. In addition, the correction analysis revealed the possible link between the identified metabolites and cecal microbiota. Conclusions This study showed regulation effects of AEE on cecal contents metabonomics profile and microbiota, which could provide information to reveal the possible underlying mechanism of AEE on hyperlipidemia treatment. |
first_indexed | 2024-12-13T02:59:43Z |
format | Article |
id | doaj.art-c09c73cfba424e84ace423a3e8406c95 |
institution | Directory Open Access Journal |
issn | 1746-6148 |
language | English |
last_indexed | 2024-12-13T02:59:43Z |
publishDate | 2018-12-01 |
publisher | BMC |
record_format | Article |
series | BMC Veterinary Research |
spelling | doaj.art-c09c73cfba424e84ace423a3e8406c952022-12-22T00:01:52ZengBMCBMC Veterinary Research1746-61482018-12-0114111510.1186/s12917-018-1711-xAspirin eugenol ester regulates cecal contents metabolomic profile and microbiota in an animal model of hyperlipidemiaNing Ma0Xi-Wang Liu1Xiao-Jun Kong2Shi-Hong Li3Zeng-Hua Jiao4Zhe Qin5Ya-Jun Yang6Jian-Yong Li7Key Lab of New Animal Drug Project of Gansu Province; Key Lab of Veterinary Pharmaceutical Development, Ministry of Agriculture, Lanzhou Institute of Husbandry and Pharmaceutical Science of Chinese Academy of Agricultural SciencesKey Lab of New Animal Drug Project of Gansu Province; Key Lab of Veterinary Pharmaceutical Development, Ministry of Agriculture, Lanzhou Institute of Husbandry and Pharmaceutical Science of Chinese Academy of Agricultural SciencesKey Lab of New Animal Drug Project of Gansu Province; Key Lab of Veterinary Pharmaceutical Development, Ministry of Agriculture, Lanzhou Institute of Husbandry and Pharmaceutical Science of Chinese Academy of Agricultural SciencesKey Lab of New Animal Drug Project of Gansu Province; Key Lab of Veterinary Pharmaceutical Development, Ministry of Agriculture, Lanzhou Institute of Husbandry and Pharmaceutical Science of Chinese Academy of Agricultural SciencesKey Lab of New Animal Drug Project of Gansu Province; Key Lab of Veterinary Pharmaceutical Development, Ministry of Agriculture, Lanzhou Institute of Husbandry and Pharmaceutical Science of Chinese Academy of Agricultural SciencesKey Lab of New Animal Drug Project of Gansu Province; Key Lab of Veterinary Pharmaceutical Development, Ministry of Agriculture, Lanzhou Institute of Husbandry and Pharmaceutical Science of Chinese Academy of Agricultural SciencesKey Lab of New Animal Drug Project of Gansu Province; Key Lab of Veterinary Pharmaceutical Development, Ministry of Agriculture, Lanzhou Institute of Husbandry and Pharmaceutical Science of Chinese Academy of Agricultural SciencesKey Lab of New Animal Drug Project of Gansu Province; Key Lab of Veterinary Pharmaceutical Development, Ministry of Agriculture, Lanzhou Institute of Husbandry and Pharmaceutical Science of Chinese Academy of Agricultural SciencesAbstract Background Hyperlipidemia, with an increasing of prevalence, has become one of the common metabolic diseases in companion animal clinic. Aspirin eugenol ester (AEE) is a novel compound that exhibits efficacious anti-hyperlipidemia activities. However, its mechanisms are still not completely known. The objective of present study was to investigate the intervention effects of AEE on cecal contents metabonomics profile and microbiota in hyperlipidemia rats. Results Three groups of rats were fed with a control diet, or high fat diet (HFD) containing or not AEE. The results showed the beneficial effects of AEE in HFD-fed rats such as the reducing of aspartate aminotransferase (AST) and total cholesterol (TCH). Distinct changes in metabonomics profile of cecal contents were observed among control, model and AEE groups. HFD-induced alterations of eight metabolites in cecal contents mainly related with purine metabolism, linoleic acid metabolism, glycerophospholipid metabolism, sphingolipid metabolism and pyrimidine metabolism were reversed by AEE treatment. Principal coordinate analysis (PCoA) and cluster analysis of microbiota showed altered patterns with distinct differences in AEE group versus model group, indicating that AEE treatment improved the negative effects caused by HFD on cecal microbiota. In addition, the correction analysis revealed the possible link between the identified metabolites and cecal microbiota. Conclusions This study showed regulation effects of AEE on cecal contents metabonomics profile and microbiota, which could provide information to reveal the possible underlying mechanism of AEE on hyperlipidemia treatment.http://link.springer.com/article/10.1186/s12917-018-1711-xAspirin eugenol esterGut microbiotaMetabonomicsCecal contentsHyperlipidemiaUPLC-Q-TOF/MS |
spellingShingle | Ning Ma Xi-Wang Liu Xiao-Jun Kong Shi-Hong Li Zeng-Hua Jiao Zhe Qin Ya-Jun Yang Jian-Yong Li Aspirin eugenol ester regulates cecal contents metabolomic profile and microbiota in an animal model of hyperlipidemia BMC Veterinary Research Aspirin eugenol ester Gut microbiota Metabonomics Cecal contents Hyperlipidemia UPLC-Q-TOF/MS |
title | Aspirin eugenol ester regulates cecal contents metabolomic profile and microbiota in an animal model of hyperlipidemia |
title_full | Aspirin eugenol ester regulates cecal contents metabolomic profile and microbiota in an animal model of hyperlipidemia |
title_fullStr | Aspirin eugenol ester regulates cecal contents metabolomic profile and microbiota in an animal model of hyperlipidemia |
title_full_unstemmed | Aspirin eugenol ester regulates cecal contents metabolomic profile and microbiota in an animal model of hyperlipidemia |
title_short | Aspirin eugenol ester regulates cecal contents metabolomic profile and microbiota in an animal model of hyperlipidemia |
title_sort | aspirin eugenol ester regulates cecal contents metabolomic profile and microbiota in an animal model of hyperlipidemia |
topic | Aspirin eugenol ester Gut microbiota Metabonomics Cecal contents Hyperlipidemia UPLC-Q-TOF/MS |
url | http://link.springer.com/article/10.1186/s12917-018-1711-x |
work_keys_str_mv | AT ningma aspirineugenolesterregulatescecalcontentsmetabolomicprofileandmicrobiotainananimalmodelofhyperlipidemia AT xiwangliu aspirineugenolesterregulatescecalcontentsmetabolomicprofileandmicrobiotainananimalmodelofhyperlipidemia AT xiaojunkong aspirineugenolesterregulatescecalcontentsmetabolomicprofileandmicrobiotainananimalmodelofhyperlipidemia AT shihongli aspirineugenolesterregulatescecalcontentsmetabolomicprofileandmicrobiotainananimalmodelofhyperlipidemia AT zenghuajiao aspirineugenolesterregulatescecalcontentsmetabolomicprofileandmicrobiotainananimalmodelofhyperlipidemia AT zheqin aspirineugenolesterregulatescecalcontentsmetabolomicprofileandmicrobiotainananimalmodelofhyperlipidemia AT yajunyang aspirineugenolesterregulatescecalcontentsmetabolomicprofileandmicrobiotainananimalmodelofhyperlipidemia AT jianyongli aspirineugenolesterregulatescecalcontentsmetabolomicprofileandmicrobiotainananimalmodelofhyperlipidemia |